JMCP Article Details Payer Perceptions of Oncology RWD During Drug Launches

August 31, 2021

In a recent article published in the Journal of Managed Care and Specialty Pharmacy (JMCP), the authors discuss the use of real world data (RWD) by payers. The study explores how RWD and real world evidence (RWE) impact payer decision-making. According to the results of a survey of 221 payers, administrative data and electronic health records are two main sources of RWE data. Payers are particularly in RWD related to outcomes, despite widespread challenges associated with this type of RWD.

The authors conclude, “As RWE is increasingly valued as a component of effective decision making in oncology, a significant educational need and opportunity exists for payers to learn about the potential impact of more broadly defined RWE to inform formulary decisions in oncology.” Read more here.

(Source: Brixner et al., JMCP, 8/21)

Share This Story!